🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher Ruel

City Of Hope National Medical Center

ORCID: 0000-0002-7205-0803

Also affiliated with City of Hope

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer”.

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03470-y
N/A
0.809DataRank · unranked
22 citations

Weihua Guo, Susan E. Yost, Xuan Ge, Jin Sun Lee, Paul Frankel +12 more

Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer

The Oncologist(2023)10.1093/oncolo/oyad026
N/A
0.580DataRank · unranked
14 citations

Susan E. Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang +10 more

Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9055
N/A
0DataRank · unranked
1 citations

Paul Frankel, Jonathan W. Riess, Anthony B. El-Khoueiry, Liza C. Villaruz, Stephen Leong +5 more

Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer

Cancers(2022)10.3390/cancers14174279
N/A
0DataRank · unranked
12 citations

Susan E. Yost, Jin Sun Lee, Paul Frankel, Christopher Ruel, Yujie Cui +13 more

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer

The Oncologist(2020)10.1002/onco.13574
N/A
0DataRank · unranked
43 citations

Jin Sun Lee, Susan E. Yost, Sierra Min Li, Paul Frankel, Christopher Ruel +17 more

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

Blood Advances(2025)10.1182/bloodadvances.2025016845
N/A
0DataRank · unranked
2 citations

Tamer Othman, Paul Frankel, Christopher Ruel, Christina Poh, Samantha Herbert +20 more

The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0305
N/A
0DataRank · unranked
1 citations

Nataliya V. Uboha, Naoko Takebe, Kit Tam, Philippe L. Bédard, Kari B. Wisinski +13 more